| 000 | a | ||
|---|---|---|---|
| 999 |
_c11070 _d11070 |
||
| 003 | OSt | ||
| 005 | 20200206113838.0 | ||
| 008 | 200206b xxu||||| |||| 00| 0 eng d | ||
| 040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
| 100 |
_911949 _aRoy, Sukalyan Saha |
||
| 245 |
_aEtoricoxib‑induced toxic epidermal necrolysis _b: A fatal case report |
||
| 250 | _aVol.50(3), May-June | ||
| 260 |
_aMumbai _bWolter Kluwer _c2018 |
||
| 300 | _a139-142p. | ||
| 520 | _aCyclooxygenase inhibitors were developed in the quest of enhanced analgesic efficacy devoid of gastric side effects. High usage of etoricoxib by prescription as well as self‑administered routes has led to increasing reports of side effects and adverse reactions including dermatologic reactions in 0.1%–0.3% of cases. The present report enumerates a case of toxic epidermal necrolysis induced by etoricoxib. | ||
| 650 | 0 |
_94774 _aPHARMACOLOGY |
|
| 700 |
_911950 _aMukherjee, Shatavisa |
||
| 773 | 0 |
_tIndian Journal of Pharmacology _dAndheri - Mumbai Wolters Kluwer India Private Limited _x0253-7613 |
|
| 856 |
_uhttp://www.ijp-online.com/temp/IndianJPharmacol503139-2189758_060457.pdf _yClick here |
||
| 942 |
_2ddc _cAR |
||